Diagnostics News and Research

RSS

Luxembourg invests in biomedical research

The Government of the Grand Duchy of Luxembourg announced on June 5, 2008 the implementation of a strategic partnership initiative with three U.S. research institutions. As part of the initiative, the Government will invest approximately 140 million euros over the next five years as it aims to develop a centre of expertise in the area of molecular medicine.

8 Jun 2008

Cancer Research UK creates 'crack teams' to solve cancer's greatest mysteries

World leading scientists are to be targeted by Cancer Research UK and its development and commercialisation arm Cancer Research Technology (CRT), in an effort to tackle some of cancer's most pressing scientific challenges.

28 May 2008

Fluorescent 'barcodes' called nanostrings could revolutionise diagnostics

A new technology with research and clinical application including the early detection of disease has been invented and developed by University of Queensland researchers.

From NanoString Technologies 22 May 2008

U.S. patent office grants re-examination of RNA splicing microarray patent on behalf of Jivan

Jivan Biologics, Inc. announced today that the United States Patent and Trademark Office has ordered the re-examination of U.S. Patent No. 6,881,571. The serial number for the reexamination is 90/009,017.

19 May 2008

Cancer Research UK and AstraZeneca announce innovative deal for promising anti-cancer compound

Cancer Research UK and Cancer Research Technology (CRT) - the charity's development and commercialisation arm - today announced an innovative new arrangement to progress into clinical development a potential anti-cancer compound from AstraZeneca.

19 May 2008

Wireless to take healthcare out of hospitals

Hospitals in the US and Europe are increasingly using wireless technology to automate patient care and back office processes. However, according to a report published by Cambridge UK based analysts, Wireless Healthcare, it is technology that supports remote care that will drive the market for wireless based medical devices and applications.

14 May 2008

Supplemental breast ultrasound boosts cancer detection, radiologist reports in national study

Among women at high-risk of developing breast cancer, breast ultrasound combined with mammography may detect more cancers than mammography alone, according to results of a multicenter trial that included UT Southwestern Medical Center researchers.

13 May 2008

Study identifies new mechanism linking activation of key heart enzyme and oxidative stress

A study, led by University of Iowa researchers, reveals a new dimension for a key heart enzyme and sheds light on an important biological pathway involved in cell death in heart disease.

1 May 2008

Increasing transmission of drug resistant tuberculosis in the UK

A changing population structure and ongoing migration have increased cases of drug resistant tuberculosis, according to a study published on bmj.com today.

1 May 2008

NIAID tackles drug-resistant tuberculosis

Tuberculosis (TB) has long been one of the world’s great killers. Now, forms of drug-resistant TB--multidrug (MDR) and extensively drug-resistant (XDR)--are occurring at an ominous and accelerating rate. To help in the fight against drug-resistant TB, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has formulated an MDR and XDR TB research agenda.

22 Apr 2008

Theranostics Health to commercialize microdissection technology from NIH

Theranostics Health announced that it has received an exclusive license from the National Institutes of Health (NIH) to commercialize microdissection including Laser Capture Microdissection (LCM) combined with protein analysis for cancer diagnostics and companion diagnostics.

21 Apr 2008

Biomoda granted 'notice of allowance' for U.S. patent protection for additional IP

Biomoda, Inc., a development stage medical diagnostics company, announced it has been granted a notice of allowance from the U.S. Patent and Trademark Office for its invention directed to the "Method for Prognosing Response to Cancer Therapy with 5,10,15,20-Tetrakis (Carboxyphenyl) Porphine."

18 Apr 2008

Salivary diagnostics

Accuracy, convenience, and non-invasiveness are the most critical characteristics for any diagnostic tool.

7 Apr 2008

Link between variant in the sequence of the human genome and susceptibility to nicotine dependence

Cigarette smoking is a major public health problem that contributes to millions of deaths around the world each year.

3 Apr 2008

Satoris enters collaboration to validate early Alzheimer's test

Satoris, Inc., a molecular diagnostics company focused on developing blood-based tests for Alzheimer ' s disease, will shortly begin a collaborative study with the Mayo Foundation for Medical Education and Research (Mayo Clinic) to validate the utility of plasma biomarkers for early detection of mild to moderate Alzheimer ' s disease.

2 Apr 2008

Astrotechnology brings nanoparticle probes into sharper focus

While pondering the challenges of distinguishing one nanosize probe image from another in a mass of hundreds or thousands of nanoprobes, two investigators at Emory University and the Georgia Institute of Technology made an interesting observation. The tiny, clustered dots of light looked a lot like a starry sky on a clear night.

27 Mar 2008

Spit in a cup to replace needle pricks

One day soon patients may spit in a cup, instead of bracing for a needle prick, when being tested for cancer, heart disease or diabetes.

26 Mar 2008

Research finds genes and processes that may underlie what makes some people more susceptible to Parkinson's disease

Better understanding of Parkinson's disease onset during aging is important for improving diagnostics and developing strategies for therapeutic intervention.

24 Mar 2008

Call to step up the fight against tuberculosis

In honor of World TB Day 2008 (March 24), the Infectious Diseases Society of America (IDSA) and the HIVMA Medicine Association (HIVMA) urged U.S. policymakers to step up the fight against tuberculosis by committing substantial resources against the disease both at home and abroad.